Coli' L, Cuna V, Capelli I, Kwin C, Donati G, La Manna G, Stefoni S
U.O. Nefrologia, Dialisi e Trapianto, Policlinico S. Orsola, Università degli Studi, Bologna.
G Ital Nefrol. 2009 Mar-Apr;26(2):154-7.
Native arteriovenous fistula is still the vascular access of choice in hemodialysis. Other options are arteriovenous graft or, in patients in whom it is not possible to create a surgical vascular access, a permanent venous catheter. International guidelines on vascular access for hemodialysis recommend an increase in the percentage of arteriovenous fistulas compared to other types of vascular access. An analysis of the data relative to the distribution of the types of vascular access in different countries highlights the difficulty in following this recommendation: the only country to have increased the number of arteriovenous fistulas in recent years is the US, where the percentage of grafts has decreased while the use of permanent catheters has increased. In Italy and the rest of Europe, the number of fistulas has remained stable, there has been a constant reduction in the number of grafts and an increase in the percentage of permanent catheters. The reasons for this distribution of the types of vascular access are multifactorial and include the increased average age of patients, frequent late referrals, and increased incidence of diabetes mellitus, cardiovascular disease, obesity, etc. These factors have brought about technical difficulties for the creation of fistulas and grafts, leading to an increase in the number of catheters used. In relation to the evolution of the clinical characteristics of dialysis patients, the permanent catheter should no longer be considered a last-choice vascular access: in selected patients, it can be a better choice than a surgical fistula or graft.
自体动静脉内瘘仍是血液透析中首选的血管通路。其他选择包括动静脉移植物,或者对于无法建立外科血管通路的患者,使用永久性静脉导管。血液透析血管通路的国际指南建议,与其他类型的血管通路相比,应提高动静脉内瘘的比例。一项关于不同国家血管通路类型分布数据的分析凸显了遵循这一建议的困难:近年来唯一增加了动静脉内瘘数量的国家是美国,该国移植物的比例下降,而永久性导管的使用增加。在意大利和欧洲其他国家,内瘘数量保持稳定,移植物数量持续减少,永久性导管的比例增加。血管通路类型呈现这种分布的原因是多方面的,包括患者平均年龄增加、频繁的延迟转诊以及糖尿病、心血管疾病、肥胖等发病率上升。这些因素给建立内瘘和移植物带来了技术困难,导致使用导管的数量增加。关于透析患者临床特征的演变,永久性导管不应再被视为最后的血管通路选择:在特定患者中,它可能比外科内瘘或移植物是更好的选择。